[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ubtf-td":3},{"name":4,"total":5,"recruiting":5,"trials":6},"UBTF-TD",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06177067","Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia",[11],"Phase 1","RECRUITING","2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.978998Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06229912","A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes",[19],"Phase 2","2026-08-26T02:19:10.436356Z","2026-05-05T02:43:26.712984Z"]